60
Participants
Start Date
September 1, 2024
Primary Completion Date
October 31, 2026
Study Completion Date
April 30, 2027
Hydroxychloroquine
Hydroxychloroquine Sulfate is an anti-malarial and anti-rheumatic drug. hydroxychloroquine has been reported to improve the clinical status of chILD cases wtih genetic causes. The exact mechanism of action of hydroxychloroquine is unknown. In additon to having anti-inflammatory properties, hydroxychloroquine has been shown to affect intracellular processing of surfactant protein.
RECRUITING
Children's hospital of Fudan University, Shanghai
Children's Hospital of Fudan University
OTHER